Haverford Trust Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Haverford Trust Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,400	Closed	-$259K	–	316
2019 Q3	$259K	Buy	+3,400	New	+$283K	﹤0.01%	267
2019 Q2	–	Sell	-2,425	Closed	-$220K	–	302
2019 Q1	$220K	Buy	+2,425	New	+$206K	﹤0.01%	278

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Haverford Trust Company's XBI Position: Q4 2019 in Review

Haverford Trust Company sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 3,400 shares — an estimated $259K sold.

Haverford Trust Company first reported a position in XBI in Q1 2019 and held it in 2 quarters. The position peaked at $259K in Q3 2019. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

Haverford Trust Company reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
Haverford Trust Company sold 3,400 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $259K.
Haverford Trust Company first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 2 quarters.
Haverford Trust Company's State Street SPDR S&P Biotech ETF position peaked at $259K in Q3 2019.
474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Haverford Trust Company's 13F filing for Q4 2019, filed 10 Feb 2020.